Keypathophysiologic pathways in age-related macular disease
- PMID: 15309554
- DOI: 10.1007/s00417-004-0976-x
Keypathophysiologic pathways in age-related macular disease
Abstract
Purpose: To review current knowledge of key pathogenetic pathways in age-related macular disease (AMD).
Methods: Experimental evidence and clinical observations are reviewed.
Results: A number of common downstream pathophysiologic pathways appear to be relevant in AMD manifestations irrespective of primary heterogeneous etiologies. These include sequelae of oxidative damage, retinal pigment epithelium (RPE) cell dysfunction with accumulation of lipofuscin and impairment of lysosomal functions, deposition of subsequently incompletely degraded material at the basal RPE cell side and alterations in Bruch's membrane extracellular matrix, immunologic responses to extracellular material (drusen) with subsequent growth of drusen, induction of choroidal neovascularization as a result of imbalance between anti-angiogenetic and proangiogenetic factors as well as cell death (geographic atrophy) without prior neovascular events.
Conclusions: Understanding is expanding regarding the sequence of events that lead to early and late lesions in AMD. Therapeutic approaches that focus on the molecular mechanisms are more likely to succeed than currently available treatment options as exemplified by the management of choroidal neovascularisations.
Similar articles
-
An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration.Prog Retin Eye Res. 2001 Nov;20(6):705-32. doi: 10.1016/s1350-9462(01)00010-6. Prog Retin Eye Res. 2001. PMID: 11587915 Review.
-
Age-related macular degeneration (AMD): pathogenesis and therapy.Pharmacol Rep. 2006 May-Jun;58(3):353-63. Pharmacol Rep. 2006. PMID: 16845209 Review.
-
Molecular mechanisms of retinal pigment epithelium damage and development of age-related macular degeneration.Acta Ophthalmol. 2012 Jun;90(4):299-309. doi: 10.1111/j.1755-3768.2011.02179.x. Epub 2011 Nov 23. Acta Ophthalmol. 2012. PMID: 22112056 Review.
-
Advanced glycation end product (AGE) accumulation on Bruch's membrane: links to age-related RPE dysfunction.Invest Ophthalmol Vis Sci. 2009 Jan;50(1):441-51. doi: 10.1167/iovs.08-1724. Epub 2008 Aug 1. Invest Ophthalmol Vis Sci. 2009. PMID: 18676633
-
Spectral profiling of autofluorescence associated with lipofuscin, Bruch's Membrane, and sub-RPE deposits in normal and AMD eyes.Invest Ophthalmol Vis Sci. 2002 Jul;43(7):2435-41. Invest Ophthalmol Vis Sci. 2002. PMID: 12091448
Cited by
-
Caspase-14 expression impairs retinal pigment epithelium barrier function: potential role in diabetic macular edema.Biomed Res Int. 2014;2014:417986. doi: 10.1155/2014/417986. Epub 2014 Jul 9. Biomed Res Int. 2014. PMID: 25121097 Free PMC article.
-
Effects of Vitreomacular Adhesion on Age-Related Macular Degeneration.J Ophthalmol. 2015;2015:865083. doi: 10.1155/2015/865083. Epub 2015 Sep 3. J Ophthalmol. 2015. PMID: 26425354 Free PMC article. Review.
-
Research resource: nuclear receptor atlas of human retinal pigment epithelial cells: potential relevance to age-related macular degeneration.Mol Endocrinol. 2011 Feb;25(2):360-72. doi: 10.1210/me.2010-0392. Epub 2011 Jan 14. Mol Endocrinol. 2011. PMID: 21239617 Free PMC article.
-
Osmotic and hypoxic induction of osteopontin in retinal pigment epithelial cells: Involvement of purinergic receptor signaling.Mol Vis. 2020 Mar 8;26:188-203. eCollection 2020. Mol Vis. 2020. PMID: 32214785 Free PMC article.
-
Obesity and eye diseases.Surv Ophthalmol. 2007 Mar-Apr;52(2):180-95. doi: 10.1016/j.survophthal.2006.12.003. Surv Ophthalmol. 2007. PMID: 17355856 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical